最近工程方法的进步为提供基于mRNA的治疗方法
Ken Ninez Nurpramesti Prinindya1, Ghulam Md Ashraf2, Shihab Uddin3
1Department of Mechanical and Industrial Engineering, Qatar University, P.O. Box 2713, Doha, Qatar.
Biomaterials advances
|January 17, 2026
概括
使者RNA (mRNA) 疗法在疫苗之外显示出很大的前景,传递系统的进步提高了有效性和安全性. 对理性设计和生物学表征的进一步研究对于临床翻译至关重要.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 治疗方法开发 治疗方法开发
背景情况:
- 使者RNA (mRNA) 干预已经彻底改变了生物医学,成功的mRNA疫苗就是一个例子.
- mRNA技术提供了诸如快速发育,有针对性的免疫反应,高效率,安全性和可扩展性等优势.
研究的目的:
- 审查治疗应用的新型mRNA输送载体和工程技术.
- 评估超越疫苗的mRNA疗法的潜力,包括蛋白质替代,癌症免疫疗法和基因编辑.
- 讨论控制释放系统和mRNA疗法的作用机制的进展.
主要方法:
- 关于新兴mRNA传递载体和工程技术的文献综述.
- 对转化效率,生物安全性和疗效的批判性评估.
- 对控制释放系统和作用机制的分析.
- 确定临床翻译的障碍.
主要成果:
- 新兴的输送系统和工程技术正在改善mRNA的治疗潜力.
- mRNA技术在蛋白质替代,癌症免疫疗法和基因编辑方面显示出前景.
- 控制释放系统提供了增强的治疗交付和作用.
结论:
- 生物安全性,稳定性和可扩展性的重大缺陷阻碍了mRNA疗法的临床翻译.
- 合理的设计和彻底的生物学表征对于充分实现mRNA治疗潜力至关重要.
- 未来的前景强调克服这些局限性,以获得更广泛的临床应用.
相关概念视频
Microorganisms in Medicine and Therapeutics
989
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
989
Regulated mRNA Transport
3.3K
3.3K
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K
The Central Dogma
32.1K
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
32.1K


